Additional information
| Active substance | Semaglutide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk |
| Lab Test | Blood glucose levels, HbA1c |
| Strength | 0.5mg/0.5ml |
| Also known as | N/A |
| Blood pressure | Can cause a reduction in blood pressure |
| Trade name | Ozempic, Rybelsus |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | Semaglutide |
| Formula | C187H291N45O59 |
| Substance class | GLP-1 receptor agonist |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 1 week |
| Dosage (medical) | 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed |
| Dosage (sports) | Not recommended for use in sports |
| Effects | Improved glycemic control, weight loss |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, decreased appetite |
| Use in sports | None, not indicated for performance enhancement |
| Manufacturer | Incepta Pharmaceuticals Ltd |
Norvacs 5 mg Pfizer
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Champix 56 tabs Pfizer
Prograf 1mg Astellas Pharma
FACTIVE 320 mg Abdi Ibragim
Norvacs 10 mg Pfizer
AVELOX 400 Bayer
Lasix Sanofi
Sibutramine Magnus Pharmaceuticals
Avory Pharma Winstrol 10mg 100 Kapseln
Clen 40 SINGANI PHARMA 

Reviews
There are no reviews yet.